|
|
 | | | |
- close
- close
- close
- close
Benzinga
Mar 14
Comment
In a research report published Thursday, Ascendiant Capital analyst Keay Nakae raised the price target from $18 to $20 on Photomedex (NASDAQ: PHMD) and maintained a Strong Buy rating after better than expected Q4 results.
In the report...
Benzinga
Mar 14
Comment
Canaccord analyst William J. Plovanic published a report on PhotoMedex (NASDAQ: PHMD) that reiterated its Neutral rating and raised the price target from $18.50 to $19.50.
Canaccord reported that, “We reiterate our BUY rating post the release...
Forbes
Jan 18
Comment
PhotoMedex (PHMD) reported its third straight quarter with a positive earnings surprise in November, amassing an average beat of 68.9% in that time. This Zacks Rank #1 (Strong Buy) skin care company has been enjoying strong earnings estimate...
Benzinga
Dec 13
Comment
Best Buy Co (NYSE: BBY) soared 12.07% to $13.65 in the pre-market trading. Best Buy's founder Richard Schulze is likely to make a fully-financed offer to acquire the company, according to the Minneapolis Star Tribune.
Clearwire (NASDAQ: CLWR)...
Benzinga
Nov 8
Comment
Ascendiant Capital raised its rating on PhotoMedex (NASDAQ: PHMD) from Buy to Strong Buy with a reiterated $18 price target.
Ascendiant Capital noted, "Revenue was $56.7 MM (+63% yoy), which was below our and consensus estimates of $58.0 MM...
StreetInsider.com
Nov 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Photomedex+%28PHMD%29+Tops+Q3+EPS+by+32c/7852204.html for the full story.
Benzinga
Aug 18
Comment
PhotoMedex, Inc. (NASDAQ: PHMD) today announced that the Board of Directors has authorized the Company to repurchase up to $25 million of its common shares in the open market over the next twelve months, at such times and prices as determined...
StreetInsider.com
Aug 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Photomedex+%28PHMD%29+Tops+Q2+EPS+by+28c/7643325.html for the full story.
Benzinga
Jul 5
Comment
OraSure Technologies (NASDAQ: OSUR) surged 10.91% to $13.42 in the pre-market session. The US Food and Drug Administration approved OraSure's OraQuick(R) In-Home HIV Test.
MannKind (NASDAQ: MNKD) added 7% to $2.75 in the pre-market session....
Benzinga
Jul 3
Comment
PhotoMedex, Inc. (Nasdaq: PHMD) today announced that Radiancy Inc., a PhotoMedex subsidiary, has entered into a settlement agreement resulting in the settlement and dismissal with prejudice of all pending litigation matters between Radiancy and...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
